TG Therapeutics Inc. (TGTX) |
|
6.75 -0.17 (-2.46%)
|
05-20 16:00 |
|
Open: |
6.82 |
Pre. Close: |
6.92 |
|
High:
|
6.91 |
Low:
|
6.705 |
|
Volume:
|
1,009,376 |
Market Cap:
|
576M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.913 - 6.959 |
6.959 - 6.998 |
|
Low:
|
6.612 - 6.657 |
6.657 - 6.694 |
|
Close:
|
6.684 - 6.757 |
6.757 - 6.818 |
|
|
|
Technical analysis |
as of: 2019-05-20 4:30:44 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 9.07 One year: 10.00 |
| Support: |
Support1: 6.48 Support2: 5.39 |
| Resistance: |
Resistance1: 7.77 Resistance2: 8.56 |
| Pivot: |
7.56 |
| Moving Average: |
MA(5): 6.92 MA(20): 7.68
MA(100): 6.21  MA(250): 8.09 |
| MACD: |
MACD(12,26): -0.22 Signal(9): -0.07 |
| Stochastic oscillator: |
%K(14,3): 21.84 %D(3): 23.24 |
| RSI: |
RSI(14): 35.92 |
| 52-week: |
High: 16.00 Low: 3.32 Change(%): -51.4 |
| Average Vol(K): |
3-Month: 240497 10-Days: 149862 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TGTX has closed above bottom band by 14.4%. Bollinger Bands are 40.5% wider than normal. The large width of the bands suggest high volatility as compared to TGTX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 10 May 2019 20:13:50 Z
Health Care Sector Update for 05/10/2019: JNJ, PFE, ABT, MRK, AMGN, GENE, PIRS, TGTX
Fri, 10 May 2019 17:58:16 Z
TG Therapeutics Inc (TGTX) Q1 2019 Earnings Call Transcript
Wed, 17 Apr 2019 17:10:36 Z
Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?
Wed, 17 Apr 2019 03:07:06 Z
Is TG Therapeutics a Buy?
Mon, 08 Apr 2019 15:09:01 Z
3 Top Biotech Stocks to Buy in April
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
90.84 |
| Shares Float (M) |
72.93 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
76.40 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est. Current Year
|
-1.840 |
|
EPS Est. Next Year
|
-1.640 |
|
EPS Est. Next Quarter
|
-0.450 |
|
Forward EPS
|
-1.960 |
|
Book Value (p.s.)
|
33.500 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-110205.26 |
|
Return on Assets (ttm)
|
-140.1 |
|
Return on Equity (ttm)
|
-319.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-134.23 |
|
Levered Free Cash Flow (M)
|
-71.45 |
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
|
|
P/BV
|
0.20 |
|
P/S
|
|
|
P/CF
|
-4.57 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2012-04-30 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
